Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Stock Position Trimmed by BML Capital Management LLC

BML Capital Management LLC reduced its stake in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) by 27.0% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,157,179 shares of the biotechnology company’s stock after selling 1,910,000 shares during the period. Adverum Biotechnologies makes up […]

Related Keywords

,Renaissance Technologies ,Geode Capital Management ,Cm Management ,Capital Management ,Adverum Biotechnologies Inc ,Bml Capital Management ,Nasdaq ,Adverum Biotechnologies ,Free Report ,Street Group ,Get Free Report ,Adverum Biotechnologies Daily ,Nasdaq Advm ,Advm ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,